BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition

Cognition Clinical Trial

Official title:

The Effectiveness of BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02166931
• Other study ID #: 201306043
• Status: Recruiting
• Phase: N/A
• Start date: March 2014
• Est. completion date: September 18, 2019

Study information

• Verified date: September 2019
• Source: Taipei Medical University Shuang Ho Hospital
• Contact: Ming-Show Hsieh, R.N.
• Phone: 886-2-22490088
• Email: 13508[@]s.tmu.edu.tw
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether BRAND'S® Essence of Chicken are effective in the promotion of resilience and resistance to stress-associated cognitive inhibition.

Description:

This is a placebo-controlled, randomized, double-blind trial. There will be 100 subjects. Subjects are randomly assigned into either placebo or BRAND'S® Essence of Chicken (BEC), 70cc daily for 2 weeks, group.

Stress test, cognitive function assessment and blood tests will be carried out at Week 0, Week 2, and Week 4 (2 weeks after termination of supplementation).

The primary end-point is the better improvement of cognitive function after supplement with BEC than placebo. The second endpoints include improvement of global health survey and changes of biomarkers related to stress and immunity.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 18, 2019
• Est. primary completion date: September 17, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• aged over 20 years,

• mildly stressed with Perceive Stress Scale (PSS) score higher than 25

• All the participants should not require medication for their mood disturbance affected by stress during the trial.

Exclusion Criteria:

• history of chronic diseases

• any psychiatric or neurological diseases (e.g. depression)

• other medical illnesses (e.g. stroke, diabetes, other cardiovascular diseases)

• allergy history to chicken

Related Conditions & MeSH terms

• Cognition
• Essence of Chicken
• Immunity
• Metabolism
• Stress Associated Cognitive Inhibition

Intervention

Dietary Supplement:
• Chicken Essence
BRAND'S® Chicken Essence of 70cc daily for 2 weeks Placebo 70 cc daily for 2 weeks

Locations

Country	Name	City	State
Taiwan	Shuang Ho Hospital, Taipei medical University	New Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University Shuang Ho Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Change from baseline in global health survey at week 2 and week 4	chinese version of SF36	baseline, week 2, week 4
Primary	Change from baseline in cognitive function at week 2 and week 4	Working memory, Episodic memory, Attention	baseline, week 2, week 4
Secondary	Change from baseline in biomarkers and and immunity related to stress at week 2 and week 4	ACTH, Cortisol, Melatonin, Glucose, BUN/CRE, GOT/GPT	baseline, week 2, week 4